Skip to main content
Clinical Trials/ACTRN12618000576224
ACTRN12618000576224
Completed
未知

Targeted antenatal smoking cessation intervention in high-risk substance dependent pregnancy: a feasibility study

Hunter New England Health Drug and Alcohol Clinical Services0 sites46 target enrollmentApril 16, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
icotine dependence
Sponsor
Hunter New England Health Drug and Alcohol Clinical Services
Enrollment
46
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 16, 2018
End Date
March 12, 2021
Last Updated
3 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Hunter New England Health Drug and Alcohol Clinical Services

Eligibility Criteria

Inclusion Criteria

  • Participants will be:
  • 1\)Pregnant women attending substance use in pregnancy services up to and including 32 weeks gestation
  • 2\)Aged \>\=16 years of age and willing and able to provide written informed consent
  • 3\)Current verified daily tobacco smokers interested in reducing smoking during pregnancy with a positive breath carbon monoxide (CO) level greater than 3 p.p.m.
  • 4\)Willing and able to comply with requirements of the study

Exclusion Criteria

  • Clients will be unable to participate if they will not be available for follow\-up

Outcomes

Primary Outcomes

Not specified

Similar Trials